BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9124195)

  • 1. Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma.
    Chitambar CR; Zahir SA; Ritch PS; Anderson T
    Am J Clin Oncol; 1997 Apr; 20(2):173-8. PubMed ID: 9124195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
    Vaughan WP; Kris E; Vose J; Bierman PJ; Gwilt P; Armitage JO
    J Clin Oncol; 1995 May; 13(5):1089-95. PubMed ID: 7738614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion.
    Warrell RP; Coonley CJ; Straus DJ; Young CW
    Cancer; 1983 Jun; 51(11):1982-7. PubMed ID: 6839291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma.
    Schilsky RL; Williams SF; Ultmann JE; Watson S
    J Clin Oncol; 1987 Mar; 5(3):419-25. PubMed ID: 3819808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic mechanisms of gallium nitrate: basic and clinical investigations.
    Chitambar CR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):39-44. PubMed ID: 15651176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience.
    Wang WS; Chiou TJ; Liu JH; Fan FS; Yen CC; Tung SL; Chen PM
    Jpn J Clin Oncol; 1999 Jan; 29(1):33-7. PubMed ID: 10073149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemotherapy of advanced lymphoma with investigational drugs: mitoguazone, gallium nitrate, and etoposide.
    Warrell RP; Danieu L; Coonley CJ; Atkins C
    Cancer Treat Rep; 1987 Jan; 71(1):47-51. PubMed ID: 3791268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study.
    Weick JK; Stephens RL; Baker LH; Jones SE
    Cancer Treat Rep; 1983 Sep; 67(9):823-5. PubMed ID: 6883359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gallium nitrate therapy on Ga-67 scintigraphic detection of lymphoma: case report.
    Akansel G; Liu Y; Chitambar CR; Kitapci MT; Akansel S; Krasnow AZ; Isitman AT; Collier BD
    Clin Nucl Med; 1997 Jan; 22(1):21-4. PubMed ID: 8993868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
    McMaster ML; Johnson DH; Greer JP; Wolff SN; Hildreth CR; Greco FA; Hainsworth JD
    Cancer; 1991 Mar; 67(6):1487-92. PubMed ID: 1705861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
    Jabboury K; Frye D; Holmes FA; Fraschini G; Hortobagyi G
    Invest New Drugs; 1989 Jul; 7(2-3):225-9. PubMed ID: 2793377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.
    Reiser M; Schnell R; Straub G; Borchmann P; Wilhelm M; Ubelacker R; Wörmann B; Münch R; Diehl V; Engert A
    Leuk Lymphoma; 1998 Oct; 31(3-4):359-66. PubMed ID: 9869200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium nitrate for the treatment of non-Hodgkin's lymphoma.
    Chitambar CR
    Expert Opin Investig Drugs; 2004 May; 13(5):531-41. PubMed ID: 15155128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
    McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
    J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma. CPT-11/Lymphoma Study Group.
    Tobinai K; Hotta T; Saito H; Ohnishi K; Ohno R; Ogura M; Ariyoshi Y; Takeyama K; Kobayashi T; Ohashi Y; Shirakawa S
    Jpn J Clin Oncol; 1996 Dec; 26(6):455-60. PubMed ID: 9001351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.
    Stoppa AM; Bouabdallah R; Chabannon C; Novakovitch G; Vey N; Camerlo J; Blaise D; Xerri L; Resbeut M; Di Stefano D; Bardou VJ; Gastaut JA; Maraninchi D
    J Clin Oncol; 1997 May; 15(5):1722-9. PubMed ID: 9164178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent.
    Vaughan WP; Bierman PJ; Reed EC; Glenn LD; Kessinger A; Armitage JO
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):110-5. PubMed ID: 1641652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.
    Chau I; Webb A; Cunningham D; Hill M; Rao S; Ageli S; Norman A; Gill K; Howard A; Catovsky D
    Br J Haematol; 2001 Dec; 115(4):786-92. PubMed ID: 11843810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.